LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
16.85
+0.37 (2.25%)
At close: Jan 6, 2026, 4:00 PM EST
16.69
-0.16 (-0.95%)
After-hours: Jan 6, 2026, 5:14 PM EST
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $527.24 million as of January 6, 2026. Its market cap has decreased by -40.85% in one year.
Market Cap
527.24M
Enterprise Value
309.12M
1-Year Change
-40.85%
Ranking
Category
Stock Price
$16.85
Market Cap Chart
Since the IPO on March 22, 2024, LENZ Therapeutics's market cap has increased from $413.64M to $527.24M, an increase of 27.46%. That is a compound annual growth rate of 14.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 515.66M | 3.00% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |